Literature DB >> 26835288

Relapsed acute myeloblastic leukemia: first pediatric randomized study.

Jan Styczynski1.   

Abstract

Entities:  

Year:  2013        PMID: 26835288      PMCID: PMC4728925          DOI: 10.3978/j.issn.2224-4336.2013.04.05

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN: 2224-4336


× No keyword cloud information.
  5 in total

1.  Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.

Authors:  Jeffrey E Rubnitz; Hiroto Inaba; Gary Dahl; Raul C Ribeiro; W Paul Bowman; Jeffrey Taub; Stanley Pounds; Bassem I Razzouk; Norman J Lacayo; Xueyuan Cao; Soheil Meshinchi; Barbara Degar; Gladstone Airewele; Susana C Raimondi; Mihaela Onciu; Elaine Coustan-Smith; James R Downing; Wing Leung; Ching-Hon Pui; Dario Campana
Journal:  Lancet Oncol       Date:  2010-05-05       Impact factor: 41.316

2.  Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML.

Authors:  Ursula Creutzig; Sylke Diekamp; Martin Zimmermann; Dirk Reinhardt
Journal:  Pediatr Blood Cancer       Date:  2007-06-15       Impact factor: 3.167

3.  Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study.

Authors:  Eva A Coenen; Susana C Raimondi; Jochen Harbott; Martin Zimmermann; Todd A Alonzo; Anne Auvrignon; H Berna Beverloo; Myron Chang; Ursula Creutzig; Michael N Dworzak; Erik Forestier; Brenda Gibson; Henrik Hasle; Christine J Harrison; Nyla A Heerema; Gertjan J L Kaspers; Anna Leszl; Nathalia Litvinko; Luca Lo Nigro; Akira Morimoto; Christine Perot; Dirk Reinhardt; Jeffrey E Rubnitz; Franklin O Smith; Jan Stary; Irina Stasevich; Sabine Strehl; Takashi Taga; Daisuke Tomizawa; David Webb; Zuzana Zemanova; Rob Pieters; C Michel Zwaan; Marry M van den Heuvel-Eibrink
Journal:  Blood       Date:  2011-05-06       Impact factor: 22.113

4.  Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group.

Authors:  Gertjan J L Kaspers; Martin Zimmermann; Dirk Reinhardt; Brenda E S Gibson; Rienk Y J Tamminga; Olga Aleinikova; Hortensia Armendariz; Michael Dworzak; Shau-Yin Ha; Henrik Hasle; Liisa Hovi; Alexei Maschan; Yves Bertrand; Guy G Leverger; Bassem I Razzouk; Carmelo Rizzari; Petr Smisek; Owen Smith; Batia Stark; Ursula Creutzig
Journal:  J Clin Oncol       Date:  2013-01-14       Impact factor: 44.544

Review 5.  Pediatric acute myeloid leukemia: towards high-quality cure of all patients.

Authors:  Gertjan J L Kaspers; Christian M Zwaan
Journal:  Haematologica       Date:  2007-11       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.